Awardee OrganizationVIRGINIA COMMONWEALTH UNIVERSITY
Description
Abstract Text
The aim of this proposal is to characterize the neural pathways that
regulate the intestinal peristaltic reflex in humans and animals, in
particular, to identify the peptide transmitters that control the sensory,
modulatory and motor limbs of the reflex. We have devised techniques to
measure the sensory and motor limbs of the reflex and neuropeptide release
associated with each, and have used various probes (specific antisera and
peptide antagonists, axonal and sensory neurotoxins and peptide immunoassay
and receptor-specific bioassay) to establish the functional coupling
between myenteric neuropeptides and each component of the reflex. We have
also devised three preparations that provide complementary information:
isolated myenteric ganglia to examine the interplay between neurons that
project within the plexus (interneurons); muscle strips with axonal
remnants only to examine the interplay between neurons that project into
circular muscle; and cultures of neurons derived from isolated myenteric
ganglia: this unique system permits predominant or exclusive expression of
one neuropeptide, and thus, identifies the singular effects of myenteric
peptides on release of the expressed peptide.
Thus far, we have shown that VIP/PHI motor neurons mediate descending
relaxation, and cholinergic and tachykinin (SP/SK) motor neurons mediate
ascending contraction. We have also shown that opioid and somatostatin
neurons act as modulatory neurons to enhance or restrain the activity of
VIP neurons. In addition, we have obtained evidence from isolated ganglia
for the existence of a feedback mechanism between somatostatin and VIP that
would enable a segment to switch from relaxation to contraction during
peristalsis.
We now propose to examine the participation of other myenteric transmitters
in the regulation of the peristaltic reflex. Preliminary studies using the
preparations listed above, show that these transmitters exert precise
modulatory effects on sensory and motor limbs of the reflex: somatostatin
as a facilitatory neuropeptide acting via inhibition of opioid peptides;
galanin as postjunctional synergist in descending pathways; GRP, CCK and
NPY as prejunctional stimulatory or inhibitory modulators; GABA as
stimulatory prejunctional modulator in ascending and descending pathways;
serotonin, depending on receptor type, as prejunctional inhibitory or
stimulatory modulator; and CGRP as sensory mediator. The approach has
provided the first characterization of the peptide transmitters that
regulate the peristaltic reflex in humans and animals.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
105300446
UEI
MLQFL4JSSAA9
Project Start Date
01-July-1984
Project End Date
30-June-1995
Budget Start Date
01-July-1990
Budget End Date
30-June-1991
Project Funding Information for 1990
Total Funding
$172,875
Direct Costs
$116,257
Indirect Costs
$56,618
Year
Funding IC
FY Total Cost by IC
1990
National Institute of Diabetes and Digestive and Kidney Diseases
$172,875
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01DK034153-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01DK034153-07
Patents
No Patents information available for 2R01DK034153-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01DK034153-07
Clinical Studies
No Clinical Studies information available for 2R01DK034153-07
News and More
Related News Releases
No news release information available for 2R01DK034153-07
History
No Historical information available for 2R01DK034153-07
Similar Projects
No Similar Projects information available for 2R01DK034153-07